Skip to main content
. 2019 Mar 29;11(4):734. doi: 10.3390/nu11040734

Table 1.

Maternal characteristics in relation to maternal use of pure iron supplements and offspring intake of iron droplets during the first 18 months of infancy.

All Maternal Use of Iron Supplements Offspring Use of Iron Droplets
No Use
(n = 15,071)
Early Use
(n = 11,092)
Late Use
(n = 48,318)
No
(n = 24,281)
Yes
(n = 27,595)
Maternal age (years) 30.4 (4.2) 30.7 (4.4) 30.7 (4.2) 30.3 (4.1) 30.5 (4.2) 30.6 (4.1)
Pre-pregnancy BMI (kg/m2)
  % underweight (<18.5) 4.3% 4.1% 5.4% 4.2% 3.9% 4.2%
  % normal weight (18.5–25) 68.2% 66.1% 70.5% 68.8% 66.4% 69.7%
  % overweight (25–30) 19.6% 20.6% 17.8% 19.4% 20.9% 18.8%
  % obese (>30) 7.9% 9.2% 6.4% 7.6% 8.8% 7.3%
Maternal Smoking, % 24.5% 27.2% 25.5% 23.4% 26.0% 21.5%
Nulliparous, % 48.4% 39.5% 41.3% 51.5% 45.5% 49.8%
Socio-economic status
  High, % 55.3% 52.7% 54.9% 56.3% 52.6% 58.9%
  Medium, % 27.2% 27.9% 28.0% 27.1% 29.8% 25.4%
  Low, % 12.2% 14.3% 12.7% 11.3% 13.0% 10.3%
  Students, % 5.3% 5.1% 4.5% 5.3% 4.6% 5.3%
Breastfeeding, %
  No 11.1% 11.6% 11.1% 10.8% 13.2% 6.3%
  1–6 months 28.4% 28.9% 28.8% 28.1% 33.3% 17.5%
  6+ months 60.6% 59.5% 60.1% 61.1% 53.5% 76.2%
Gestational age at delivery (days) 280.2 (12.4) 280.8 (11.5) 280.9 (21.9) 280.8 (11.2) 281.1 (10.8) 279.8 (13.0)
Cesarean section, % 15.3% 14.1% 13.8% 15.2% 15.1% 15.1%
Maternal celiac disease (n,%) 172, 0.25% 36, 0.24% 45, 0.41% 122, 0.25% 57, 0.23% 64, 0.24%
Maternal type 1 diabetes (n,%) 332, 0.49% 77, 0.51% 44, 0.40% 232, 0.48% 114, 0.47% 137, 0.53%
Maternal anemia (n,%) 1916, 3.5% 427, 3.6% 606, 7.0% 1374, 3.5% 732, 3.6% 804, 3.5%

Early use = before gestational week 20; late use = after gestational week 20; Body Mass Index, BMI.